Skip to main content

Table 4 Patients’ characteristics

From: Renal involvement and metabolic alterations in adults patients affected by cystic fibrosis

 

eGFR < 90 mL/min/1,73 m2

eGFR 90–119 mL/min/1.73 m2

eGFR > 120 mL/min/1.73 m2

Total

Mutationclass I

25% (7 pts)

39.3% (11 pts)

35.7% (10 pts)

28

Mutationclass II

24.7% (39 pts)

45.6% (72 pts)

29.7% (47 pts)

158

Mutationclass III

0

66.7% (2 pts)

33.3% (1 pts)

3

Mutationclass IV

62.5% (5 pts)

25% (2 pts)

12.5% (1 pts)

8

Mutationclass V

33.3% (4 pts)

41.7% (5 pts)

25% (3 pts)

12

Total

26.3% (55 pts)

44% (92 pts)

29.7% (62 pts)

209

p value (using Chi squared test (χ2 8df)

   

0.467

  1. Data are shown as Average ± SD; Stratification into three groups according to eGFR for each CFTR mutation class
  2. eGFR estimated Glomerular Filtration Rate, pts patients